|
SRGAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.323800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.08770000000347E-05 |
| Normal-vs-Stage2 |
1.654760E-01 |
| Normal-vs-Stage3 |
2.911200E-01 |
| Normal-vs-Stage4 |
3.602000E-01 |
| Stage1-vs-Stage2 |
2.362200E-01 |
| Stage1-vs-Stage3 |
2.439900E-03 |
| Stage1-vs-Stage4 |
5.740100E-03 |
| Stage2-vs-Stage3 |
4.913800E-01 |
| Stage2-vs-Stage4 |
4.790000E-01 |
| Stage3-vs-Stage4 |
9.397000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.296800E-03 |
| Normal-vs-AfricanAmerican |
2.248200E-01 |
| Normal-vs-Asian |
2.362000E-01 |
| Caucasian-vs-AfricanAmerican |
7.389800E-01 |
| Caucasian-vs-Asian |
4.245800E-01 |
| AfricanAmerican-vs-Asian |
4.850600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.993970E-02 |
| Normal-vs-Female |
4.245400E-04 |
| Male-vs-Female |
7.344400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.782000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.379900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.541200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.318200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.180200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.193200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.378400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.316600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.295400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.672000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.99200000003697E-07 |
| Normal-vs-Grade 2 |
1.91133999999371E-05 |
| Normal-vs-Grade 3 |
2.108200E-01 |
| Normal-vs-Grade 4 |
6.770000E-01 |
| Grade 1-vs-Grade 2 |
2.839900E-02 |
| Grade 1-vs-Grade 3 |
2.44079999999203E-05 |
| Grade 1-vs-Grade 4 |
3.52380000000485E-05 |
| Grade 2-vs-Grade 3 |
1.951710E-04 |
| Grade 2-vs-Grade 4 |
4.604000E-04 |
| Grade 3-vs-Grade 4 |
5.146600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.19199999981667E-07 |
| Normal-vs-ccB subtype |
3.887600E-01 |
| ccA subtype-vs-ccB subtype |
1.82582000000098E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.739300E-03 |
| Normal-vs-N1 |
1.518560E-01 |
| N0-vs-N1 |
9.871600E-01 |
|
|
